These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3621257)

  • 1. [Inhibitory activity of D-600 on smooth vascular tissue: comparison with nifedipine, verapamil and diltiazem].
    Raddino R; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 May; 32(5):469-72. PubMed ID: 3621257
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM; Ayad MJ; Robertson RM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydralazine and D-600 on KCl induced contraction and phosphorylase activation in rabbit aorta.
    Diamond J; Shaikh MI
    Proc West Pharmacol Soc; 1980; 23():45-8. PubMed ID: 7403164
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of calcium channel blocking agents on oxygen consumption rate in vascular smooth muscle.
    Flaim SF; Irwin JM; Ratz PH; Swigart SC
    Am J Cardiol; 1982 Feb; 49(3):511-8. PubMed ID: 6277177
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle.
    Towart R; Wehinger E; Meyer H; Kazda S
    Arzneimittelforschung; 1982; 32(4):338-46. PubMed ID: 7201802
    [No Abstract]   [Full Text] [Related]  

  • 11. Different sensitivities for four calcium entry blockers of serotonin-, but not K+-induced contractions of isolated jugular vein and aorta of the rat.
    Gouw MA; Wilffert B; van Zwieten PA
    Pharmacology; 1989; 38(5):289-97. PubMed ID: 2762372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and vascular smooth muscle.
    Flaim SF
    Prog Clin Biol Res; 1986; 219():311-52. PubMed ID: 3786324
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by methoxyverapamil of the responses of smooth muscle from spontaneously hypertensive and normotensive rats.
    Nghiem C; Swamy VC; Triggle DJ
    Blood Vessels; 1982; 19(4):177-85. PubMed ID: 7082851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium channel blockers and smooth muscle motility in vitro.
    Gintautiene K; Matook AE; Abadir AR; Estafan MY; Bhangdia P; Silverstein JH; Gintautas J
    Proc West Pharmacol Soc; 1987; 30():141-3. PubMed ID: 3628266
    [No Abstract]   [Full Text] [Related]  

  • 16. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of lidocaine on contraction of isolated rabbit aortic rings].
    Zhang ZH; Li ST; Jiang MZ; Wen Y; Bu X
    Yao Xue Xue Bao; 1994; 29(9):652-5. PubMed ID: 7900535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of calcium antagonists on the portal vein].
    Oomiya A; Kokumi N; Hagiwara Y; Hara T; Hirashima T
    Nihon Heikatsukin Gakkai Zasshi; 1985 Aug; 21(4):266-8. PubMed ID: 4094226
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of calcium antagonists on coronary spasm and pulmonary artery contraction in comparison to their antagonistic action against K-strophanthin in isolated guinea pig atria.
    Lindner E; Ruppert D
    Pharmacology; 1982; 24(5):294-302. PubMed ID: 7100259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.